April 11 (Reuters) - Prana Biotechnology PBT.AX
* Prana Biotechnology says regains compliance with NASDAQ continued listing requirements
* Prana Biotechnology says continues to focus on its submission to U.S. FDA to lift partial clinical hold Source text for Eikon: Further company coverage: PBT.AX
(Bengaluru Newsroom: +1 646 223 8780)